Studies involving disease:Tuberculosis
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000234 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv1130 | M. tuberculosis | Weill Cornell Medicine |
| ST000262 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv1713 | M. tuberculosis | Weill Cornell Medicine |
| ST000263 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv1016 | M. tuberculosis | Weill Cornell Medicine |
| ST000264 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3280 | M. tuberculosis | Weill Cornell Medicine |
| ST000265 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3244 | M. tuberculosis | Weill Cornell Medicine |
| ST000266 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3801 | M. tuberculosis | Weill Cornell Medicine |
| ST000267 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3722c | M. tuberculosis | Weill Cornell Medicine |
| ST000268 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3311 | M. tuberculosis | Weill Cornell Medicine |
| ST000786 | N-acetylisoputreanine-g-lactam Identification | Human | Colorado State University |
| ST000931 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3915 (CwlM) | M. tuberculosis | Weill Cornell Medicine |
| ST000932 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv0100 | M. tuberculosis | Weill Cornell Medicine |
| ST000935 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv2553c | M. tuberculosis | Weill Cornell Medicine |
| ST000936 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv2247 | M. tuberculosis | Weill Cornell Medicine |
| ST000937 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3208 | M. tuberculosis | Weill Cornell Medicine |
| ST000940 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3285 | M. tuberculosis | Weill Cornell Medicine |
| ST000941 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3651 | M. tuberculosis | Weill Cornell Medicine |
| ST000942 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3799c | M. tuberculosis | Weill Cornell Medicine |
| ST000943 | Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3916c | M. tuberculosis | Weill Cornell Medicine |
| ST000974 | GC6-74 matabolomic of TB (Part 1: Plasma) | Human | Max Planck Institute for Infection Biology |
| ST000975 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Human | Max Planck Institute for Infection Biology |
| ST000976 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Human | Max Planck Institute for Infection Biology |
| ST001069 | Evaluation of Seryl-leucine core 1 O-glycosylated peptide (SLC1G) in TB patient urine | Human | Colorado State University |
| ST001104 | Seryl-leucine core 1 O-glycosylated peptide (SLC1G) identification | Human | Colorado State University |
| ST001231 | Plasma untargeted metabolomics study of pulmonary tuberculosis | Human | Zhengjiang University |
| ST001328 | Multiplatform, non-targeted analysis of lung extracts of uninfected and Mtb-infected C57BL/6 mice at 4 and 9 weeks p.i. | Mouse | Universidad CEU San Pablo |
| ST001378 | Global metabolomics of COPD2020 | Human | Seoul National University Hospital |
| ST002428 | Mass Spectrometry-based Proteomic and Metabolomic profiling of serum samples for discovery and validation of Tuberculosis diagnostic biomarker signature | Human | ITQB NOVA |
| ST002911 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Mouse | Universidad CEU San Pablo |
